Haleon (HLNCF) Asset Utilization Ratio (2023)

Haleon (HLNCF) recorded quarterly Asset Utilization Ratio of 0.32 in Q4 2023.

Haleon (HLNCF) Asset Utilization Ratio (2023) Analysis & Trends

Haleon has disclosed Asset Utilization Ratio across 1 years of filings, most recently posting 0.32 for Q4 2023.

Quarterly Asset Utilization Ratio changed N/A year-over-year to 0.32 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 0.32 (changed N/A YoY) and the FY2025 annual result came in at 0.33, up 0.51% from the prior year.
Asset Utilization Ratio held at 0.32 in Q4 2023.
Over five years, Asset Utilization Ratio peaked at 0.32 in Q4 2023 and troughed at 0.32 in Q4 2023.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn	0.43
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn	0.62
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn	0.43
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn	0.48
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn	0.65
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn	0.37
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn	0.36
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn	1.07
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn	0.68
10	Haleon	-	-	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2023	0.32